Literature DB >> 29706825

Medulloblastoma in a toddler with Gorlin syndrome.

Mohamad G Al-Rahawan1, Sorleen Trevino2, Roy Jacob3, Jeffrey C Murray4, Mohamad M Al-Rahawan2.   

Abstract

Gorlin syndrome (GS) is a rare hereditary multisystem disorder caused by mutations in PTCH1, PTCH2, or SUFU. It is characterized by multiple anomalies and an increased risk of developing various tumors. Basal cell carcinoma is most common, and medulloblastoma (MB) is especially frequent in patients with SUFU mutations. MB treatment often includes radiation therapy in patients older than 3 years; however, such treatment is very toxic to patients with GS. Most reported cases of MB in patients with GS present after GS is diagnosed. We report a male toddler with multicentric posterior fossa tumor and calcifications along the falx cerebri, suggesting MB and GS. Pathology revealed nodular MB. His testing confirmed a germline SUFU mutation. His tumor resolved with three induction cycles of chemotherapy, but he died of respiratory failure due to infection at 20 months of age. Overlooking calcifications along the falx cerebri in children with MB can induce significant morbidity.

Entities:  

Keywords:  Falx cerebri; Gorlin syndrome; SUFU mutation; medulloblastoma

Year:  2018        PMID: 29706825      PMCID: PMC5914436          DOI: 10.1080/08998280.2018.1435111

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  11 in total

1.  Consensus statement from the first international colloquium on basal cell nevus syndrome (BCNS).

Authors:  Alanna F Bree; Maulik R Shah
Journal:  Am J Med Genet A       Date:  2011-08-10       Impact factor: 2.802

2.  Germline mutations in SUFU cause Gorlin syndrome-associated childhood medulloblastoma and redefine the risk associated with PTCH1 mutations.

Authors:  Miriam J Smith; Christian Beetz; Simon G Williams; Sanjeev S Bhaskar; James O'Sullivan; Beverley Anderson; Sarah B Daly; Jill E Urquhart; Zaynab Bholah; Deemesh Oudit; Edmund Cheesman; Anna Kelsey; Martin G McCabe; William G Newman; D Gareth R Evans
Journal:  J Clin Oncol       Date:  2014-11-17       Impact factor: 44.544

Review 3.  Tailoring Medulloblastoma Treatment Through Genomics: Making a Change, One Subgroup at a Time.

Authors:  Borja L Holgado; Ana Guerreiro Stucklin; Livia Garzia; Craig Daniels; Michael D Taylor
Journal:  Annu Rev Genomics Hum Genet       Date:  2017-05-05       Impact factor: 8.929

4.  High frequency of germline SUFU mutations in children with desmoplastic/nodular medulloblastoma younger than 3 years of age.

Authors:  Laurence Brugières; Audrey Remenieras; Gaëlle Pierron; Pascale Varlet; Sébastien Forget; Véronique Byrde; Johny Bombled; Stéphanie Puget; Olivier Caron; Christelle Dufour; Olivier Delattre; Brigitte Bressac-de Paillerets; Jacques Grill
Journal:  J Clin Oncol       Date:  2012-04-16       Impact factor: 44.544

Review 5.  Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome.

Authors:  V E Kimonis; A M Goldstein; B Pastakia; M L Yang; R Kase; J J DiGiovanna; A E Bale; S J Bale
Journal:  Am J Med Genet       Date:  1997-03-31

6.  Pilot Study of Intensive Chemotherapy With Peripheral Hematopoietic Cell Support for Children Less Than 3 Years of Age With Malignant Brain Tumors, the CCG-99703 Phase I/II Study. A Report From the Children's Oncology Group.

Authors:  Bruce H Cohen; J Russell Geyer; Douglas C Miller; John G Curran; Tianni Zhou; Emi Holmes; Sue Ann Ingles; Ira J Dunkel; Joanne Hilden; Roger J Packer; Ian F Pollack; Amar Gajjar; Jonathan L Finlay
Journal:  Pediatr Neurol       Date:  2015-04-09       Impact factor: 3.372

7.  Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032.

Authors:  Giles W Robinson; Brent A Orr; Gang Wu; Sridharan Gururangan; Tong Lin; Ibrahim Qaddoumi; Roger J Packer; Stewart Goldman; Michael D Prados; Annick Desjardins; Murali Chintagumpala; Naoko Takebe; Sue C Kaste; Michael Rusch; Sariah J Allen; Arzu Onar-Thomas; Clinton F Stewart; Maryam Fouladi; James M Boyett; Richard J Gilbertson; Tom Curran; David W Ellison; Amar Gajjar
Journal:  J Clin Oncol       Date:  2015-07-13       Impact factor: 44.544

Review 8.  Medulloblastoma in childhood: new biological advances.

Authors:  John R Crawford; Tobey J MacDonald; Roger J Packer
Journal:  Lancet Neurol       Date:  2007-12       Impact factor: 44.182

Review 9.  Risk stratification of childhood medulloblastoma in the molecular era: the current consensus.

Authors:  Vijay Ramaswamy; Marc Remke; Eric Bouffet; Simon Bailey; Steven C Clifford; Francois Doz; Marcel Kool; Christelle Dufour; Gilles Vassal; Till Milde; Olaf Witt; Katja von Hoff; Torsten Pietsch; Paul A Northcott; Amar Gajjar; Giles W Robinson; Laetitia Padovani; Nicolas André; Maura Massimino; Barry Pizer; Roger Packer; Stefan Rutkowski; Stefan M Pfister; Michael D Taylor; Scott L Pomeroy
Journal:  Acta Neuropathol       Date:  2016-04-04       Impact factor: 17.088

10.  Delayed diagnosis of Gorlin syndrome: Learning from mistakes!

Authors:  Subramaniyan Ramanathan; Devendra Kumar; Mahmoud Al Heidous; Yegu Palaniappan
Journal:  J Pediatr Neurosci       Date:  2015 Oct-Dec
View more
  1 in total

Review 1.  Gorlin Syndrome: Recent Advances in Genetic Testing and Molecular and Cellular Biological Research.

Authors:  Shoko Onodera; Yuriko Nakamura; Toshifumi Azuma
Journal:  Int J Mol Sci       Date:  2020-10-13       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.